Form D · Biotechnology

IQuity Labs, Inc.

Nashville, TN · CIK 0001639887

Offering snapshot reported Mar 21, 2016 · SEC filing

Reported sold
$2M
Indefinite offering
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 6, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1M$2MApr 22, 2015: $600,000.00Apr 22, 2015Oct 16, 2015: $1,750,000.00Oct 16, 2015Mar 21, 2016: $2,000,000.00Mar 21, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$600,000 → $2,000,000
  • Reported investors2 → 19

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 21, 2016Amendment$2,000,000$1,400,000vs Apr 22, 201519SEC filing
Oct 16, 2015Amendment$1,750,000$1,150,000vs Apr 22, 201514SEC filing
Apr 22, 2015Initial$600,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-238420

Source: Form D, filed Mar 21, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Julia B. Polk Director, Executive
Charles Floyd Spurlock Iii Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4015 Hillsboro Pike, Suite 214
Nashville, TN, 37215